Amylyx Pharmaceuticals Inc.

06/13/2022 | Press release | Distributed by Public on 06/13/2022 05:17

Amylyx Pharmaceuticals Announces Health Canada Approval of ALBRIOZA™ for the Treatment of ALS - Form 8-K